• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Microbiol . Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice

tetano

Editor, Senior Moderator
Front Microbiol


. 2024 Oct 2:15:1466980.
doi: 10.3389/fmicb.2024.1466980. eCollection 2024. Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice

Amany Elsharkawy[SUP] 1 2 [/SUP], Shannon Stone[SUP] 1 [/SUP], Anchala Guglani[SUP] 1 [/SUP], Lila D Patterson[SUP] 1 [/SUP], Chunyu Ge[SUP] 3 [/SUP], Chinonye Dim[SUP] 1 [/SUP], Joseph M Miano[SUP] 3 [/SUP], Mukesh Kumar[SUP] 1 2 [/SUP]



Affiliations
Abstract

Owing to their continuous evolution, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) display disparate pathogenicity in mouse models. Omicron and its sublineages have been dominant worldwide. Compared to pre-Omicron VOCs, early Omicron subvariants reportedly cause attenuated disease in human ACE-2-expressing mice (K18-hACE-2). In late 2022, the frequency of Omicron subvariant XBB.1.5 rapidly increased and it progressively replaced other circulating strains. The emergence of new strains requires current SARS-CoV-2 clinical animal model re-evaluation. In this study, we aim to characterize XBB.1.5 pathogenesis in K18-hACE-2. Herein, we demonstrated that XBB.1.5 infection is associated with significant weight loss, severe lung pathology, and substantial mortality. Intranasal XBB.1.5 infection resulted in 100% mortality in K18-hACE2 mice. High virus titers were detected in the lungs on days 3 and 5 after infection. Moreover, XBB.1.5 productively infected the cells within the nasal turbinate, olfactory bulb, intestines, and kidneys. In addition, in a subset of infected mice, we detected high virus titers in the brain. Consistently, we detected high viral antigen expression in the lungs. Furthermore, we observed severe lung injury hallmarks (e.g., immune cell infiltration, perivascular cuffing, and alveolar consolidation). Using immunofluorescence labeling and cytometric analysis, we revealed that XBB.1.5 infection leads to CD45[SUP]+[/SUP] cell influx into the lung parenchyma. We further demonstrated that most immune infiltrates are CD11b[SUP]+[/SUP] CD11c[SUP]+[/SUP] dendritic cells. Additionally, we detected significant induction of proinflammatory cytokines and chemokines in infected lungs. Taken together, our data show that Omicron subvariant XBB.1.5 is highly pathogenic in K18-hACE2 mice.

Keywords: ACE-2 expressing mice; COVID-19; SARS-CoV-2 variants of concern; XBB.1.5; inflammation.

 
Back
Top Bottom